drugset / Trial / NCT01276106
Study of AC-201 in Patients With Type 2 Diabetes Mellitus
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a 24-week randomized placebo-controlled study to investigate the effect of an oral IL-1beta inhibitor AC-201 in patients with type 2 diabetes mellitus already treated on different background diabetes therapies.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-02
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diacerein | Small molecule | 25 mg | Oral |
| Subject | Diacerein | Small molecule | 50 mg | Oral |
| Subject | Diacerein | Small molecule | 75 mg | Oral |